Sign in
CompletedNo phase

Impact on the Use of Antibiotics of a Multimodal Algorithm for the Diagnosis and Management of Acute Community-acquired Pneumonia in the Emergency Room

Key facts

Who runs it
Assistance Publique - Hôpitaux de Paris
Where
France2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
295 people enrolled
Started
9 Jan 2023
Ended
11 Jun 2024
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • CRP dosage
  • multiplex PCR
  • chest scan without injection
Record updated
16 October 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Patient 18 years or older
  • Presence of at least one respiratory sign among the following: dyspnea, cough, expectoration, auscultatory abnormalities, chest pain
  • Presence of at least one general sign among the following: fever (T>38°C), hypothermia (T<35°C), myalgia, headache, asthenia
  • Oxygen-requiring patient defined by a saturation <95% or presenting a risk area among:; Age > 65 years old; Alcoholic and/or tobacco intoxication; Congestive heart failure; Cerebrovascular disease (stroke or transient ischemic attack); Chronic kidney disease (excluding dialysis); Chronic liver disease; Unbalanced diabetes mellitus; Progressive neoplastic disease; Immunodepression (systemic corticosteroid therapy or immunosuppressive treatment within 6 months, splenectomy, chemotherapy within 6 months, HIV at the AIDS stage, cachexia, etc.); Homozygous sickle cell disease; Bacterial pneumonia; Hospitalization during the year; Institutional life; Non-inclusion Criteria:
  • Patient unable to consent: coma or acute respiratory distress requiring orotracheal intubation
  • Patient with chronic renal failure on dialysis
  • Patient with a history of chronic obstructive pulmonary disease
  • Lung transplant patient
  • Patient being treated with antibiotics at the time of the emergency room consultation
  • Patient simultaneously participating in an interventional study protocol (assessing the duration of antibiotic therapy)
  • Pregnant or breastfeeding woman
  • Patient refusal to participate
  • Patient deprived of freedom or under a legal protective measure
  • Patient under guardianship or curatorship or with cognitive impairment
  • Non-affiliation to a social security regimen or CMU

Who cannot take part

  • RT-PCR positive for SARS-CoV-2

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Reducing antibiotics prescription is still to date, the main goal in low respiratory tract infections (LRTI).

Read full original descriptionShow less

Several studies have shown conflicting results on the impact of multiplex PCR as a point of care tool. Our experience has highlighted an impact on single room assignments during the winter season but not yet on antibiotics prescriptions. This project aims to evaluate a new multimodal algorithm including multiplex PCR at the point of care to reduce antibiotics prescription and therefore has the ability to have a positive impact on antibiotics resistance phenomenon.

The 2 groups in the trial

  • Intervention periodTreatment being tested

    Patient management will be guided by a multimodal algorithm integrating the performance of biological and iconographic examinations

    Treatment: CRP dosage, multiplex PCR, and chest scan without injection

  • Control periodNo study treatment, for comparison

    Patient management will be done according to the usual practices of centers and emergency physicians

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
16 October 2024